Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $1.78 Analyst target: $1280.00 Upside: 71810.11%
Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.